SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
450.00    -3.60 (-0.79%)
Bid:
451.30
Ask:
451.60
Spread: 0.30 (0.066%)
Market Cap: £11.32b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q3 Trading Update

18 Oct 2018 07:00

RNS Number : 4043E
Rentokil Initial PLC
18 October 2018
 

RENTOKIL INITIAL PLC (RTO) - THIRD QUARTER TRADING UPDATE

18 October 2018

 

 

(£m)

Q3 2018

Growth

AER

AER

CER

Ongoing Revenue1

637.4

10.2%

11.8%

Revenue

641.1

6.3%

8.2%

 

Overview (CER)

 

Ongoing Revenue increased by 11.8% in Q3, of which 4.1% was Organic Revenue2 growth (H1 2018: 3.0%, Q3 2017: 3.7%) and 7.7% was from acquisitions. Adjusting for the impact of Hurricane Irma on our operations in Puerto Rico in September 2017, Group Organic growth was 4.4%.

Pest Control grew by 11.4% (5.3% Organic and 5.7% adjusting for Puerto Rico), with good performances being delivered across both Growth and Emerging markets. The business enjoyed favourable weather conditions across Europe and the UK which has supported stronger jobbing revenues. North America grew Ongoing Revenue by 12.1% (4.6% Organic and 5.3% adjusting for Puerto Rico).

Hygiene revenues increased by 22.0% (2.8% Organic) reflecting continued progress from initiatives to drive Organic growth and the contribution from the acquisitions of Cannon Hygiene Services and CWS Italy. Ongoing Revenue in our Protect & Enhance markets grew by 0.7% (0.7% Organic) reflecting improvements in France Workwear and Ambius. Ongoing market weakness continued to impact the performance of our UK Property Care business in the third quarter, albeit this was at an improved rate of decline compared to H1. 

M&A

​We acquired 16 businesses (14 in Pest Control, one in Hygiene and one in Ambius) across all our regions in Q3 with annualised revenues of £39.0m. For the year to 30 September 2018 we have acquired a total of 39 businesses (34 in Pest Control, four in Hygiene and one in Ambius) primarily in Emerging and Growth markets. Annualised revenues of the businesses acquired so far in 2018 totalled £156.3m in the year prior to purchase. Our M&A pipeline going into Q4 and 2019 remains strong.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with the performance of the group in the third quarter. We continue to successfully deploy our market-leading innovations and digital applications to our customers and to execute our value-creating M&A programme, and we remain on track to meet expectations for the full year."

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

 

 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

 

AER - actual exchange rates; CER - constant 2016 exchange rates

 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTZMMMGNNMGRZM
Date   Source Headline
25th Nov 20193:25 pmRNSHolding(s) in Company
14th Nov 20194:00 pmRNSHolding(s) in Company
8th Nov 20195:30 pmRNSHolding(s) in Company
8th Nov 20199:40 amRNSDirector/PDMR Shareholding
6th Nov 20195:00 pmRNSHolding(s) in Company
5th Nov 20195:10 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSAcquisition of Florida Pest Control, USA
31st Oct 20194:30 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Update
30th Sep 201910:20 amRNSBlock listing Interim Review
23rd Sep 201910:30 amRNSHolding(s) in Company
13th Sep 20194:00 pmRNSDirector/PDMR Shareholding
19th Aug 20193:15 pmRNSDirector/PDMR Shareholding
5th Aug 20191:58 pmRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSAppointment of Joint Corporate Broker
2nd Jul 201910:35 amRNSPost Stabilisation Notice
21st Jun 20197:00 amRNSDirectorate Change
11th Jun 201912:00 pmRNSHolding(s) in Company
31st May 20195:00 pmRNSHolding(s) in Company
30th May 20195:00 pmRNSDirector Declaration
17th May 20194:04 pmRNSDirector/PDMR Shareholding
15th May 20199:30 amRNSPre Stabilisation Notice
8th May 20192:30 pmRNSResult of AGM
29th Apr 201911:40 amRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSQ1 Trading Update
12th Apr 20196:25 pmRNSDirector/PDMR Shareholding - Replacement
11th Apr 20194:37 pmRNSDirector/PDMR Shareholding
10th Apr 20191:57 pmRNSDirector Declaration
1st Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
27th Mar 201911:18 amRNSAnnual Financial Report
25th Mar 20199:58 amRNSDirector/PDMR Shareholding
12th Mar 201912:17 pmRNSDirector/PDMR Shareholding
6th Mar 20192:00 pmRNSAdditional Listing
6th Mar 20191:05 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSInnovative good causes initiative
28th Feb 20195:15 pmRNSDirector/PDMR Shareholding
28th Feb 20197:05 amRNSDirectorate Changes and Appointment of Chairman
28th Feb 20197:00 amRNSFinal Results
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.